Foresee Pharmaceuticals Co (ROCO:6576) Total Stockholders Equity : NT$1,328.6 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Foresee Pharmaceuticals Co Total Stockholders Equity?

Foresee Pharmaceuticals Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$1,328.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Foresee Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2025 was NT$8.58. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Foresee Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.12.

Foresee Pharmaceuticals Co Total Stockholders Equity Historical Data

The historical data trend for Foresee Pharmaceuticals Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Foresee Pharmaceuticals Co Total Stockholders Equity Chart

Foresee Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

1,829.23

1,320.17

910.58

1,244.51

1,599.00

Foresee Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,149.89	1,000.29	704.10	1,599.00	1,328.59

Foresee Pharmaceuticals Co (ROCO:6576) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Foresee Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1328.586	-	0)	/	154.849
	=	8.58

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Foresee Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(64.173	+	91.667)	/	1328.586
	=	0.12

Foresee Pharmaceuticals Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Foresee Pharmaceuticals Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Foresee Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Foresee Pharmaceuticals Co Ltd (ROCO:6576) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19-3, Sanchong Road, 9th Floor-2, Nangang District, Taipei, TWN, 115

Website

https://www.foreseepharma.com

Foresee Pharmaceuticals Co Ltd is engaged in the development and commercialization of new drugs using its proprietary drug delivery technology. Its main activity is to apply its Stabilized injectable formulation(SIF) platform technology to produce the products for anticancer and treatment of chronic disease. Its SIF product pipeline includes FP-001 for prostate cancer, FP-004 for Opioid drug addiction/Pain, FP-011 for Breast Cancer/Prostate Cancer, FP-016 for neurological diseases, and others. All of its revenue is generated from Taiwan.

Foresee Pharmaceuticals Co Headlines

No Headlines